TruSpine Technologies Plc

Director's Dealing • Apr 26, 2023

National Storage Mechanism | Additional information

RNS Number : 5447X

TruSpine Technologies PLC

26 April 2023

26 April 2023

TruSpine Technologies plc

("TruSpine" or the "Company")

Shareholder Requisition Notice

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has received an email dated 14 April 2023 from Janice Stone, Peter Houghton, Todd Michael Cramer and Christopher Blank (together the "Named Shareholders"), who hold in excess of 5 per cent. of the issued share capital of the Company, requiring that the Company convene, as soon as reasonably practicable, a general meeting ("Requisition").

The board changes proposed by the Named Shareholders are:

i.      that Norman Lott be removed as a director and company secretary of the Company;

ii.     that Nikunj Patel be removed as a director of the Company;

iii.    that Annabel Schild be removed as a director of the Company;

iv.   that Laurence Strauss be removed as a director of the Company;

v.    that Todd Michael Cramer be appointed as a director of the Company;

vi.   that Peter Houghton be appointed as a director of the Company;

vii.  that Anthony Swoboda be appointed a director of the Company; and

viii. that the adjourned 2022 annual general meeting be re-convened as soon as reasonably practical.

The letter is a requisition by the Named Shareholders under section 303 of the Companies Act 2006.

The Company is mindful that, pursuant to section 304 of the Companies Act 2006, the Company must post a notice convening a general meeting within 21 days from the date on which the requisition was received, and this meeting must be held on a date not more than 28 days after the date of the notice to shareholders convening the general meeting.

A further announcement will be made regarding a general meeting in due course.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.

Enquiries:

TruSpine Technologies Plc	Tel: +44 (0)20 3638 5025
Laurence Strauss, Chief Executive Officer
Cairn Financial Advisers LLP (AQSE Corporate Adviser)	Tel: +44 (0)20 7213 0880
Liam Murray / Ludovico Lazzaretti
Oberon Capital (Joint Broker)	Tel: +44 (0)20 3179 5300
Mike Seabrook / Chris Crawford
Peterhouse Capital Limited (Joint Broker & Financial Adviser)	Tel: +44 (0)20 7469 0930
Lucy Williams / Duncan Vasey
Novus Communications (PR and IR)	Tel: +44 (0)207 448 9839
Alan Green / Jacqueline Briscoe	[email protected]

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXIFMLTMTJTMTJ